The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Nimodipine-Global Market Insights and Sales Trends 2025
Synopsis
Nimodipine, sold under the brand name Nimotop among others, is a calcium channel blocker originally developed for the treatment of high blood pressure.
The global Nimodipine market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Nimodipine in various end use industries. The expanding demands from the Hospital, Pharmacy, Clinics and Others, are propelling Nimodipine market. Capsule, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Solution segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Nimodipine market, driven by demand from China, the second largest economy with some signs of stabilising, the Nimodipine market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Nimodipine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Nimodipine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Nimodipine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Nimodipine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Nimodipine covered in this report include Bayer, Azurity, Avet Pharmaceuticals Inc., Bionpharma, Reyoung Pharmaceutical and Cisen Pharmaceutical, etc.
The global Nimodipine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bayer
Azurity
Avet Pharmaceuticals Inc.
Bionpharma
Reyoung Pharmaceutical
Cisen Pharmaceutical
Global Nimodipine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Nimodipine market, Segment by Type:
Capsule
Solution
Tablets
Global Nimodipine market, by Application
Hospital
Pharmacy
Clinics
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Nimodipine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Nimodipine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Nimodipine, sold under the brand name Nimotop among others, is a calcium channel blocker originally developed for the treatment of high blood pressure.
The global Nimodipine market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Nimodipine in various end use industries. The expanding demands from the Hospital, Pharmacy, Clinics and Others, are propelling Nimodipine market. Capsule, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Solution segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Nimodipine market, driven by demand from China, the second largest economy with some signs of stabilising, the Nimodipine market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Nimodipine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Nimodipine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Nimodipine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Nimodipine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Nimodipine covered in this report include Bayer, Azurity, Avet Pharmaceuticals Inc., Bionpharma, Reyoung Pharmaceutical and Cisen Pharmaceutical, etc.
The global Nimodipine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bayer
Azurity
Avet Pharmaceuticals Inc.
Bionpharma
Reyoung Pharmaceutical
Cisen Pharmaceutical
Global Nimodipine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Nimodipine market, Segment by Type:
Capsule
Solution
Tablets
Global Nimodipine market, by Application
Hospital
Pharmacy
Clinics
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Nimodipine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Nimodipine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Nimodipine Market Overview
1.1 Nimodipine Product Overview
1.2 Nimodipine Market Segment by Type
1.2.1 Capsule
1.2.2 Solution
1.2.3 Tablets
1.3 Global Nimodipine Market Size by Type
1.3.1 Global Nimodipine Market Size Overview by Type (2018-2029)
1.3.2 Global Nimodipine Historic Market Size Review by Type (2018-2023)
1.3.3 Global Nimodipine Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Nimodipine Sales Breakdown by Type (2018-2023)
1.4.2 Europe Nimodipine Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Nimodipine Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Nimodipine Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Nimodipine Sales Breakdown by Type (2018-2023)
2 Global Nimodipine Market Competition by Company
2.1 Global Top Players by Nimodipine Sales (2018-2023)
2.2 Global Top Players by Nimodipine Revenue (2018-2023)
2.3 Global Top Players by Nimodipine Price (2018-2023)
2.4 Global Top Manufacturers Nimodipine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Nimodipine Market Competitive Situation and Trends
2.5.1 Nimodipine Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Nimodipine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nimodipine as of 2022)
2.7 Date of Key Manufacturers Enter into Nimodipine Market
2.8 Key Manufacturers Nimodipine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Nimodipine Status and Outlook by Region
3.1 Global Nimodipine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Nimodipine Historic Market Size by Region
3.2.1 Global Nimodipine Sales in Volume by Region (2018-2023)
3.2.2 Global Nimodipine Sales in Value by Region (2018-2023)
3.2.3 Global Nimodipine Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Nimodipine Forecasted Market Size by Region
3.3.1 Global Nimodipine Sales in Volume by Region (2024-2029)
3.3.2 Global Nimodipine Sales in Value by Region (2024-2029)
3.3.3 Global Nimodipine Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Nimodipine by Application
4.1 Nimodipine Market Segment by Application
4.1.1 Hospital
4.1.2 Pharmacy
4.1.3 Clinics
4.1.4 Others
4.2 Global Nimodipine Market Size by Application
4.2.1 Global Nimodipine Market Size Overview by Application (2018-2029)
4.2.2 Global Nimodipine Historic Market Size Review by Application (2018-2023)
4.2.3 Global Nimodipine Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Nimodipine Sales Breakdown by Application (2018-2023)
4.3.2 Europe Nimodipine Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Nimodipine Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Nimodipine Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Nimodipine Sales Breakdown by Application (2018-2023)
5 North America Nimodipine by Country
5.1 North America Nimodipine Historic Market Size by Country
5.1.1 North America Nimodipine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Nimodipine Sales in Volume by Country (2018-2023)
5.1.3 North America Nimodipine Sales in Value by Country (2018-2023)
5.2 North America Nimodipine Forecasted Market Size by Country
5.2.1 North America Nimodipine Sales in Volume by Country (2024-2029)
5.2.2 North America Nimodipine Sales in Value by Country (2024-2029)
6 Europe Nimodipine by Country
6.1 Europe Nimodipine Historic Market Size by Country
6.1.1 Europe Nimodipine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Nimodipine Sales in Volume by Country (2018-2023)
6.1.3 Europe Nimodipine Sales in Value by Country (2018-2023)
6.2 Europe Nimodipine Forecasted Market Size by Country
6.2.1 Europe Nimodipine Sales in Volume by Country (2024-2029)
6.2.2 Europe Nimodipine Sales in Value by Country (2024-2029)
7 Asia-Pacific Nimodipine by Region
7.1 Asia-Pacific Nimodipine Historic Market Size by Region
7.1.1 Asia-Pacific Nimodipine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Nimodipine Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Nimodipine Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Nimodipine Forecasted Market Size by Region
7.2.1 Asia-Pacific Nimodipine Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Nimodipine Sales in Value by Region (2024-2029)
8 Latin America Nimodipine by Country
8.1 Latin America Nimodipine Historic Market Size by Country
8.1.1 Latin America Nimodipine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Nimodipine Sales in Volume by Country (2018-2023)
8.1.3 Latin America Nimodipine Sales in Value by Country (2018-2023)
8.2 Latin America Nimodipine Forecasted Market Size by Country
8.2.1 Latin America Nimodipine Sales in Volume by Country (2024-2029)
8.2.2 Latin America Nimodipine Sales in Value by Country (2024-2029)
9 Middle East and Africa Nimodipine by Country
9.1 Middle East and Africa Nimodipine Historic Market Size by Country
9.1.1 Middle East and Africa Nimodipine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Nimodipine Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Nimodipine Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Nimodipine Forecasted Market Size by Country
9.2.1 Middle East and Africa Nimodipine Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Nimodipine Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Bayer
10.1.1 Bayer Company Information
10.1.2 Bayer Introduction and Business Overview
10.1.3 Bayer Nimodipine Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Bayer Nimodipine Products Offered
10.1.5 Bayer Recent Development
10.2 Azurity
10.2.1 Azurity Company Information
10.2.2 Azurity Introduction and Business Overview
10.2.3 Azurity Nimodipine Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Azurity Nimodipine Products Offered
10.2.5 Azurity Recent Development
10.3 Avet Pharmaceuticals Inc.
10.3.1 Avet Pharmaceuticals Inc. Company Information
10.3.2 Avet Pharmaceuticals Inc. Introduction and Business Overview
10.3.3 Avet Pharmaceuticals Inc. Nimodipine Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Avet Pharmaceuticals Inc. Nimodipine Products Offered
10.3.5 Avet Pharmaceuticals Inc. Recent Development
10.4 Bionpharma
10.4.1 Bionpharma Company Information
10.4.2 Bionpharma Introduction and Business Overview
10.4.3 Bionpharma Nimodipine Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Bionpharma Nimodipine Products Offered
10.4.5 Bionpharma Recent Development
10.5 Reyoung Pharmaceutical
10.5.1 Reyoung Pharmaceutical Company Information
10.5.2 Reyoung Pharmaceutical Introduction and Business Overview
10.5.3 Reyoung Pharmaceutical Nimodipine Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Reyoung Pharmaceutical Nimodipine Products Offered
10.5.5 Reyoung Pharmaceutical Recent Development
10.6 Cisen Pharmaceutical
10.6.1 Cisen Pharmaceutical Company Information
10.6.2 Cisen Pharmaceutical Introduction and Business Overview
10.6.3 Cisen Pharmaceutical Nimodipine Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Cisen Pharmaceutical Nimodipine Products Offered
10.6.5 Cisen Pharmaceutical Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Nimodipine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Nimodipine Industrial Chain Analysis
11.4 Nimodipine Market Dynamics
11.4.1 Nimodipine Industry Trends
11.4.2 Nimodipine Market Drivers
11.4.3 Nimodipine Market Challenges
11.4.4 Nimodipine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Nimodipine Distributors
12.3 Nimodipine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
